HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin
However, New Hampshire lawmakers recently introduced a bill (SB455-FN) that would, if passed, require certain fully insured commercial health plans to cover GLP-1 medications under certain circumstances
In clinical trials, Wegovy helped people lose an average of 15% of their body weight over 68 weeks
Tretinoin (prescription retinoid): 4 of 10 (40%)
The global burden of cardiovascular diseases and risk: A compass for future health
Supplement instructions advise taking one of each daily